Once the inquiry from your medical institution, the ultimate prescription content material is transmitted with the healthcare institution to your information system when the prescription drug is determined. When an coverage pharmacy inquires about the availability of insurance policy for prescribed drugs explained in prescriptions, the existence / absence with the inquiry record Using the health care establishment and the final results are dispersed. Eventually, a number of inquiry histories is distributed for the evaluation and payment institution and also the insurer, and the information inquiry / judgment process is completed.
結果として、医療サービス受給の公平性を保ちつつ、代替品が存在する医薬品の中で、被保険者・保険者や審査支払機関が、効果・価格等の観点から望ましいと考える医薬品を選択する機会が十分に提供されていない。
次に、図２を用いて本発明の手段が実行されるフローを時系列で説明する。本発明の手段の実行は情報システムを通じて行われるが、この実行は大別して、システムの準備段階及び運用段階の二段階に分けられる。
Though each line has a definite character, alongside one another they variety a whole medication determination support Resolution, serving a big selection of healthcare markets and providing constant content and aligned methods encompassing both equally drug reference and drug knowledge.
以下に、図４を用いて情報照会・判定の手順の一例のフローチャートを説明する。まず審査支払機関・保険者・保険医療機関・保険薬局から必要な情報を取得する。審査支払機関及び保険者から取得する情報・指定条件は前述の通りであり、医療機関・保険薬局からは所在地等の基本情報に加え、使用希望薬剤情報・医薬品取扱情報・同在庫情報等を取得し、取得したデータを格納する。
請求項１に記載の医薬品処方情報照会・配信システムにおいて、医療機関が発行した処方箋に記されている医薬品の保険適用につき、保険薬局からの照会を受付け、処方箋発行医療機関との照会履歴の有無、結果について配信することを特徴とする医薬品処方情報照会・配信システム。
Must your health-related medical professional wants the pharmacist to give you a specific brand of medication, they've got to precisely Observe this or sign-up the space sent.
You believe in us Along with the health and wellness needs, and we just take that accountability pretty severely. That features guaranteeing that the details is Harmless and guarded—and more info that you've Command.
図１は、本発明の医薬品処方情報照会・配信方法を活用したビジネスモデルの一例の概略を示す図面であり、図２は、当該ビジネスモデルをより具体的に示す図面であり、図３は、情報システム構成の一例を示す図面であり、図４は、情報照会・判定の一例を示すフローチャートであり、図５は、本発明の医薬品処方情報照会・配信のための情報システム内のデータファイルの一例を示す図面であり、図６は、当該情報システムと接続した医療機関の端末の入出力イメージの一例を示す図である。
Total the shape then simply click the containers to point the type of information you want to receive.
This A Component of the prescription is made up of Guidelines for that pharmacist, within the party of a drug if it should be compounded from the pharmacy.
Consider therapy modification - knowledge reveal that the desired brokers may communicate with each other inside a clinically-sizeable fashion and patient-certain assessment has to be performed to determine no matter whether some great benefits of concomitant therapy outweigh the hazards. Certain actions needs to be taken in order to realize the benefits and/or minimize toxicity of concomitant use. Steer clear of mixture - knowledge display that the desired brokers could interact with one another in the clinically-major way and the risk usually outweighs any possible advantage. Concurrent use of these brokers is mostly considered contraindicated. Test Interactions - Listing of assay interferences when related
Up coming, the movement during which the signifies of your existing invention is executed might be described in time sequence with reference to FIG.
・ It is not meant to grow the options for prescription drugs of insurers and minimize the expense of pharmaceuticals. On top of that, PBM in The us presents drug Expense administration companies for corporations including providers as the leading customers and doesn't protect all citizens. will not be.